Phase II Study of PF-04948568 (CDX-110) in Patients With Glioblastoma Multiforme - No Study Results Posted

Phase II Study of PF-04948568 (CDX-110) in Patients With Glioblastoma Multiforme (ACT III)

This study is ongoing, but not recruiting participants.

Study NCT00458601 Information provided by Pfizer

First Received: April 10, 2007 Last Updated: October 26, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2012
Estimated Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)